EcoDrugPlus

Aryl Hydrocarbon Receptor

Ensembl ID : ENSMPUG00000013964
Gene Symbol: AHR
1 Cross references
154 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSMPUG00000006233
Gene Symbol: AURKA
2 Cross references
233 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSMPUG00000008152
Gene Symbol: AURKB
2 Cross references
205 Possible Orthologues:

Aurora Kinase C

Ensembl ID : ENSMPUG00000006397
Gene Symbol: AURKC
2 Cross references
96 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSMPUG00000004353
Gene Symbol: BACE1
4 Cross references
217 Possible Orthologues:

Bradykinin Receptor B1

Ensembl ID : ENSMPUG00000003087
Gene Symbol: BDKRB1
2 Cross references
147 Possible Orthologues:

Butyrylcholinesterase

Ensembl ID : ENSMPUG00000009957
Gene Symbol: BCHE
2 Cross references
130 Possible Orthologues:

Calcitonin Receptor Like Receptor

Ensembl ID : ENSMPUG00000012254
Gene Symbol: CALCRL
2 Cross references
147 Possible Orthologues:

Calcium Sensing Receptor

Ensembl ID : ENSMPUG00000004798
Gene Symbol: CASR
2 Cross references
202 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 1

Ensembl ID : ENSMPUG00000018296
Gene Symbol: CACNA2D1
4 Cross references
285 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 2

Ensembl ID : ENSMPUG00000013014
Gene Symbol: CACNA2D2
2 Cross references
272 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 3

Ensembl ID : ENSMPUG00000016833
Gene Symbol: CACNA2D3
2 Cross references
307 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).